What is Vivani Medical's G&A?

Vivani Medical (VANI) reported G&A of $2.43M in Q1 2026.

How has Vivani Medical's G&A changed year-over-year?

Vivani Medical's G&A increased by 3.7% year-over-year, from $2.34M to $2.43M.

What is the long-term trend for Vivani Medical's G&A?

Over 4 years (2021 to 2025), Vivani Medical's G&A has grown at a 17.2% compound annual growth rate (CAGR), from $5M to $9.43M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Vivani Medical VANI G&A

G&A at other companies

AltimmuneALT

$8.05M+34.4%

Viking TherapeuticsVKTX

$13.98M-0.7%

Wave Life SciencesWVE

$22.1M+20.4%

Prime MedicinePRME

$17.41M+31.0%

MBX Biosciences, Inc.MBX

$8.79M+113%

Other financials

Income statement

See full

Revenue-—

Gross profit$130.0K—

Operating income-$6.8M-4.0%

Net income-$6.8M-7.6%

EPS (diluted)-$0.08+27.3%

Balance sheet

See full

Cash & equivalents$19.0M+57.7%

Total debt$18.3M-3.5%

Total equity$19.1M+64.2%

Total assets$42.4M+19.5%

Cash flow

See full

Operating cash flow-$6.2M-20.0%

CapEx$3.0K-40.0%

Free cash flow-$6.2M-19.9%

Valuation

See full

Market cap$106.93M+40.0%

Enterprise value$106.17M+19.3%

Profitability

See full

Gross margin36.3%—

Operating margin-1,004.9%—

Net margin-994.1%—

FCF margin-832.3%—

Returns & leverage

See full

Return on equity-176.4%+175pp

Debt / equity1×-0.7×

Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vivani Medical's G&A?: Vivani Medical (VANI) reported G&A of $2.43M in Q1 2026.
How has Vivani Medical's G&A changed year-over-year?: Vivani Medical's G&A increased by 3.7% year-over-year, from $2.34M to $2.43M.
What is the long-term trend for Vivani Medical's G&A?: Over 4 years (2021 to 2025), Vivani Medical's G&A has grown at a 17.2% compound annual growth rate (CAGR), from $5M to $9.43M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.